Article R5121-9-8
Decisions to include a medicinal product in the register of hybrid groups, to amend these decisions and to remove a medicinal product from this register, governed by this section, are published on the…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 3321–3330 of 51458 articles for “Art. Cass. 3e Civ. 9-2-2005 n° 197 FS-PB”
Decisions to include a medicinal product in the register of hybrid groups, to amend these decisions and to remove a medicinal product from this register, governed by this section, are published on the…
Decisions to include a medicinal product on the reference list of similar biological groups, to amend these decisions and to remove it from this list are published on the website of the Agence nationa…
The request for an opinion from the Agence nationale de sécurité du médicament et des produits de santé by the ministers responsible for health and social security, on the order mentioned in the last…
With a view to their inclusion in the register of hybrid groups mentioned in the last paragraph of Article L. 5121-10, hybrid medicinal products are identified by a decision of the Director General of…
I.-When a medicinal product, which is the subject of a compassionate access authorisation, obtains a marketing authorisation, the Director General of the Agence nationale de sécurité du médicament et…
The modelling agency licence is issued for an indefinite period by the Prefect of Paris. The Ile-de-France Regional Director for Business, Competition, Consumer Affairs, Labour and Employment examines…
The Director General of the Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail or the applicant for marketing authorisation may refer the matter to the European…
Authorisation for thoracic oncology surgery with B2 may only be granted if the health care establishment has an organisation enabling it to guarantee on-site access to an extracorporeal circulation te…
When the holder of the surgical oncology authorisation implements a hybrid practice of surgical oncology management with the administration of a systemic cancer drug treatment intraoperatively or in t…
I.- By way of derogation from the provisions of article R. 6123-87-1, a holder of a surgical oncology authorisation who has rare specific equipment included on a list drawn up by order of the Minister…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More